MBIO
Price
$1.53
Change
+$0.02 (+1.32%)
Updated
Sep 2 closing price
Capitalization
11.08M
PROK
Price
$2.30
Change
-$0.06 (-2.54%)
Updated
Sep 2 closing price
Capitalization
310.49M
76 days until earnings call
Interact to see
Advertisement

MBIO vs PROK

Header iconMBIO vs PROK Comparison
Open Charts MBIO vs PROKBanner chart's image
Mustang Bio
Price$1.53
Change+$0.02 (+1.32%)
Volume$109.86K
Capitalization11.08M
ProKidney
Price$2.30
Change-$0.06 (-2.54%)
Volume$1.25M
Capitalization310.49M
MBIO vs PROK Comparison Chart in %
Loading...
MBIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PROK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
MBIO vs. PROK commentary
Sep 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MBIO is a Buy and PROK is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 03, 2025
Stock price -- (MBIO: $1.53 vs. PROK: $2.30)
Brand notoriety: MBIO and PROK are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MBIO: 1% vs. PROK: 7%
Market capitalization -- MBIO: $11.08M vs. PROK: $310.49M
MBIO [@Biotechnology] is valued at $11.08M. PROK’s [@Biotechnology] market capitalization is $310.49M. The market cap for tickers in the [@Biotechnology] industry ranges from $102.81B to $0. The average market capitalization across the [@Biotechnology] industry is $1.88B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MBIO’s FA Score shows that 0 FA rating(s) are green whilePROK’s FA Score has 0 green FA rating(s).

  • MBIO’s FA Score: 0 green, 5 red.
  • PROK’s FA Score: 0 green, 5 red.
According to our system of comparison, PROK is a better buy in the long-term than MBIO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MBIO’s TA Score shows that 2 TA indicator(s) are bullish while PROK’s TA Score has 3 bullish TA indicator(s).

  • MBIO’s TA Score: 2 bullish, 6 bearish.
  • PROK’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, PROK is a better buy in the short-term than MBIO.

Price Growth

MBIO (@Biotechnology) experienced а +1.32% price change this week, while PROK (@Biotechnology) price change was -3.36% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.48%. For the same industry, the average monthly price growth was +24.35%, and the average quarterly price growth was +32.72%.

Reported Earning Dates

PROK is expected to report earnings on Nov 18, 2025.

Industries' Descriptions

@Biotechnology (+0.48% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PROK($310M) has a higher market cap than MBIO($11.1M). PROK YTD gains are higher at: 39.645 vs. MBIO (-82.938). MBIO has higher annual earnings (EBITDA): -5.6M vs. PROK (-157.52M). PROK has more cash in the bank: 295M vs. MBIO (12.7M). MBIO has less debt than PROK: MBIO (0) vs PROK (4.42M). PROK has higher revenues than MBIO: PROK (527K) vs MBIO (0).
MBIOPROKMBIO / PROK
Capitalization11.1M310M4%
EBITDA-5.6M-157.52M4%
Gain YTD-82.93839.645-209%
P/E Ratio0.77N/A-
Revenue0527K-
Total Cash12.7M295M4%
Total Debt04.42M-
FUNDAMENTALS RATINGS
MBIO: Fundamental Ratings
MBIO
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
91
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
65
P/E GROWTH RATING
1..100
68
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
MBIOPROK
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 5 days ago
77%
Bullish Trend 5 days ago
72%
Momentum
ODDS (%)
Bearish Trend 5 days ago
90%
Bullish Trend 5 days ago
66%
MACD
ODDS (%)
Bearish Trend 5 days ago
89%
N/A
TrendWeek
ODDS (%)
Bearish Trend 5 days ago
90%
Bearish Trend 5 days ago
69%
TrendMonth
ODDS (%)
Bearish Trend 5 days ago
90%
Bearish Trend 5 days ago
72%
Advances
ODDS (%)
Bullish Trend 6 days ago
81%
Bullish Trend 6 days ago
73%
Declines
ODDS (%)
Bearish Trend 8 days ago
90%
Bearish Trend 14 days ago
80%
BollingerBands
ODDS (%)
N/A
Bullish Trend 5 days ago
74%
Aroon
ODDS (%)
Bearish Trend 5 days ago
90%
Bearish Trend 5 days ago
77%
View a ticker or compare two or three
Interact to see
Advertisement
MBIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PROK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
IMRN1.830.01
+0.55%
Immuron Limited
HTLD8.590.01
+0.12%
Heartland Express
AGYS109.120.03
+0.03%
Agilysys
SBAC204.85-1.19
-0.58%
SBA Communications Corp
CABA1.45-0.05
-3.33%
Cabaletta Bio

MBIO and

Correlation & Price change

A.I.dvisor indicates that over the last year, MBIO has been loosely correlated with SLRX. These tickers have moved in lockstep 63% of the time. This A.I.-generated data suggests there is some statistical probability that if MBIO jumps, then SLRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MBIO
1D Price
Change %
MBIO100%
-2.27%
SLRX - MBIO
63%
Loosely correlated
+1.41%
PROK - MBIO
51%
Loosely correlated
-5.60%
IPHYF - MBIO
42%
Loosely correlated
N/A
SCNI - MBIO
37%
Loosely correlated
+4.79%
MIRM - MBIO
34%
Loosely correlated
-2.20%
More

PROK and

Correlation & Price change

A.I.dvisor indicates that over the last year, PROK has been loosely correlated with CYCC. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if PROK jumps, then CYCC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PROK
1D Price
Change %
PROK100%
-5.60%
CYCC - PROK
57%
Loosely correlated
+5.31%
MBIO - PROK
51%
Loosely correlated
-2.27%
RLYB - PROK
45%
Loosely correlated
-4.21%
RYTM - PROK
40%
Loosely correlated
-1.04%
NRIX - PROK
39%
Loosely correlated
-0.74%
More